Terveystalo, Finland’s largest private healthcare provider listed on Nasdaq Helsinki, has agreed to acquire Silmäasema. Silmäasema is Finland’s leading vision care and eye health group, offering ophthalmology and optometry services alongside optical products.. In Estonia, Silmäasema operates 10 optical shops under the Eagle Vision brand. Following the completion of the transaction, Coronaria, Silmäasema’s largest shareholder, will become the largest shareholder of Terveystalo.
The transaction strengthens Terveystalo’s position in the growing eye care market, creating a broader platform for accelerated growth and improved profitability. The combined company will serve approximately two million customers with an expanded range of services and products, with combined annual revenue of approximately EUR 1.55 billion in 2025. Customers will benefit from Terveystalo’s digital capabilities and comprehensive healthcare offering combined with Silmäasema’s specialist vision care and eye health platform.
COBALT is Terveystalo’s Estonian legal counsel in this transaction. Our team included Partner Jesse Kivisaari, Senior Associate Liina Saaremets, and Associate Paul Schifrin.
